Pharmacokinetic-pharmacodynamic interaction between nebicapone, a novel catechol-O-methyltransferase inhibitor, and controlled-release levodopa/carbidopa 200 mg/50 mg: Randomized, double-blind, placebo-controlled, crossover study in healthy subjects - Vaz-Da-Silva, M.; Loureiro, A.I.; Nunes, T.; Lopes, C.; Rocha, J.; MacHado, R.; Costa, R.; Torrão, L.; Falcão, A.; Wright, L.; Almeida, L.; Soares-Da-Silva, P. (Drugs in R and D, 2008)
Cited By (since 1996): 4Export Date: 18 March 2013Source: Scopus